Last reviewed · How we verify
NCT05981820
High Intensity Interval Training, Creatine Intake and Anaerobic Power
NA trial testing Creatine in Creatine in 15 participants. Completed in 15 January 2023.
1 August 2022
Quick facts
| Lead sponsor | Ankara University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 10 March 2022 |
| Primary completion | 1 August 2022 |
| Estimated completion | 15 January 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Creatine (CREATINE) — full drug profile →
- HIIT training
Conditions studied
- Creatine — all drugs for Creatine →
- High Intensity Interval Training — all drugs for High Intensity Interval Training →
Sponsor
Ankara University
Who can join
Adults 18 to 30, male only, with Creatine or High Intensity Interval Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Creatine is an ergogenic aid with positive effects on muscle and performance. The aim of the study was to determine whether there is a difference between the effects of creatine supplementation taken together with Wingate-based HIIT on anaerobic power, leg strength, heart rate variability and body composition. In the study, Wingate-based HIIT program was applied three days a week for six weeks. Anaerobic power (Wingate anaerobic power test), heart rate variability (Polar H10 chest band), leg strength (back and leg dynamometer) and body composition (PlusAvis 333) measurements of the participants were made 1 week before the training program started and the week after the training program ended. Twenty physically active adult men aged 18-30 were voluntarily included for the study. Participants were divided into two groups: Wingate-based HIIT with creatine supplementation (K-HIIT) and Wingate-based HIIT only (HIIT). As a result of the analysis, it was seen that creatine supplementation taken together with wingate-based HIIT had an effect and increased on the anaerobic power parameters, peak power, average power and minimum power values, and leg strength. In addition, it was determined that heart rate variability parameters improved heart rate (HR, beat/min) and low frequency (LF, ms2) values, but did not cause any change in body composition. Comparing and investigating the effects of different HIIT methods on anaerobic power, leg strength, heart rate variability and body composition will increase the generalizability of the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Combination of High-Intensity Interval Training and Creatine Intake Enhances Leg Strength and Anaerobic Power without Changes in Body Composition in Physically Active Adult Men
Erdogmus TN, Aras D, Gulu M, Aldhahi MI, et al · · 2023 · DOI 10.21203/rs.3.rs-3304243/v1
Verify or expand the search:
- PubMed search for NCT05981820
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Creatine
Trials testing the same drug.
- NCT07372144 — Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment · Phase 3 · not yet recruiting
- NCT06883292 — The Effects of Tyrosol and Creatine on Endurance, Strength, and Fatigue Resistance in Healthy Adults · NA · completed
- NCT06675708 — Effectiveness of Creatine on Pain, Fatigue, and Muscle Architectural Variables in Patients Witg Fibromyalgia. · NA · enrolling by invitation
- NCT06395506 — THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation · NA · recruiting
- NCT06594406 — The Effect of Oral Bifidobacterium on Exogenous Creatine Absorption in Adult Subjects · NA · completed
Other Ankara University trials
Trials by the same sponsor.
- NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
- NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
- NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
- NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
- NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05981820 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara University
- Last refreshed: 8 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05981820.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing